Search
Now showing items 1-8 of 8
MIF antagonists are anti-diabetogenic.
(Abstracts of Papers of the American Chemical Society, 2004)
Immunosuppressive and anti-inflammatory action of antioxidants in rat autoimmune diabetes
(Journal of Autoimmunity, 2004)
Inducible nitric oxide synthase activation by interleukin-17
(Elsevier, 2004)
Inducible nitric oxide synthase inhibition by mycophenolic acid
(Bentham Science Publishers Ltd., 2004)
Iron down-regulates macrophage anti-tumour activity by blocking nitric oxide production
(Blackwell Publishing Ltd, 2004)
5-Aza-2 '-deoxycytidine and paclitaxel inhibit inducible nitric oxide synthase activation in fibrosarcoma cells
(European Journal of Pharmacology, 2004)